Skip to Main Content

Paper Details

Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate.
Clin Pharmacol Ther
71
2014
Author NameAffiliation
Taimour Y LangaeeDepartment of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, University of Florida College of Pharmacy
Ben BurkleyDepartment of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, University of Florida College of Pharmacy
Stephen T TurnerMayo Clinic College of Medicine
Rhonda M Cooper-DeHoff1] Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, University of Florida College of Pharmacy, University of Florida College of Medicine
Julie A Johnson1] Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, University of Florida College of Pharmacy, University of Florida College of Medicine
  • 1 - 5

Datasets